233 related articles for article (PubMed ID: 25605372)
21. MOZ directs the distal-less homeobox gene expression program during craniofacial development.
Vanyai HK; Garnham A; May RE; McRae HM; Collin C; Wilcox S; Smyth GK; Thomas T; Voss AK
Development; 2019 Jul; 146(14):. PubMed ID: 31340933
[TBL] [Abstract][Full Text] [Related]
22. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
Yin H; Glass J; Blanchard KL
Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
[TBL] [Abstract][Full Text] [Related]
23. Histone H2AX suppresses translocations in lymphomas of Eμ-c-Myc transgenic mice that contain a germline amplicon of tumor-promoting genes.
Fusello A; Horowitz J; Yang-Iott K; Brady BL; Yin B; Rowh MA; Rappaport E; Bassing CH
Cell Cycle; 2013 Sep; 12(17):2867-75. PubMed ID: 23966158
[TBL] [Abstract][Full Text] [Related]
24. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Eischen CM; Alt JR; Wang P
Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
[TBL] [Abstract][Full Text] [Related]
25. The role of MOZ/KAT6A in hematological malignancies and advances in MOZ/KAT6A inhibitors.
Su J; Wang X; Bai Y; Sun M; Yao Y; Duan Y
Pharmacol Res; 2021 Dec; 174():105930. PubMed ID: 34626770
[TBL] [Abstract][Full Text] [Related]
26. MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells.
Yang XJ; Ullah M
Oncogene; 2007 Aug; 26(37):5408-19. PubMed ID: 17694082
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
28. The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence.
Wall M; Poortinga G; Stanley KL; Lindemann RK; Bots M; Chan CJ; Bywater MJ; Kinross KM; Astle MV; Waldeck K; Hannan KM; Shortt J; Smyth MJ; Lowe SW; Hannan RD; Pearson RB; Johnstone RW; McArthur GA
Cancer Discov; 2013 Jan; 3(1):82-95. PubMed ID: 23242809
[TBL] [Abstract][Full Text] [Related]
29. moz regulates Hox expression and pharyngeal segmental identity in zebrafish.
Miller CT; Maves L; Kimmel CB
Development; 2004 May; 131(10):2443-61. PubMed ID: 15128673
[TBL] [Abstract][Full Text] [Related]
30. IBTK contributes to B-cell lymphomagenesis in Eμ-myc transgenic mice conferring resistance to apoptosis.
Vecchio E; Golino G; Pisano A; Albano F; Falcone C; Ceglia S; Iaccino E; Mimmi S; Fiume G; Giurato G; Britti D; Scala G; Quinto I
Cell Death Dis; 2019 Apr; 10(4):320. PubMed ID: 30975981
[TBL] [Abstract][Full Text] [Related]
31. MOZ regulates the Tbx1 locus, and Moz mutation partially phenocopies DiGeorge syndrome.
Voss AK; Vanyai HK; Collin C; Dixon MP; McLennan TJ; Sheikh BN; Scambler P; Thomas T
Dev Cell; 2012 Sep; 23(3):652-63. PubMed ID: 22921202
[TBL] [Abstract][Full Text] [Related]
32. Reduction of Prep1 levels affects differentiation of normal and malignant B cells and accelerates Myc driven lymphomagenesis.
Iotti G; Mejetta S; Modica L; Penkov D; Ponzoni M; Blasi F
PLoS One; 2012; 7(10):e48353. PubMed ID: 23133585
[TBL] [Abstract][Full Text] [Related]
33. Endogenous bcl-2 is not required for the development of Emu-myc-induced B-cell lymphoma.
Kelly PN; Puthalakath H; Adams JM; Strasser A
Blood; 2007 Jun; 109(11):4907-13. PubMed ID: 17317859
[TBL] [Abstract][Full Text] [Related]
34. Mesodermal expression of Moz is necessary for cardiac septum development.
Vanyai HK; Thomas T; Voss AK
Dev Biol; 2015 Jul; 403(1):22-9. PubMed ID: 25912687
[TBL] [Abstract][Full Text] [Related]
35. MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP.
Deguchi K; Ayton PM; Carapeti M; Kutok JL; Snyder CS; Williams IR; Cross NC; Glass CK; Cleary ML; Gilliland DG
Cancer Cell; 2003 Mar; 3(3):259-71. PubMed ID: 12676584
[TBL] [Abstract][Full Text] [Related]
36. Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation.
Kitabayashi I; Aikawa Y; Yokoyama A; Hosoda F; Nagai M; Kakazu N; Abe T; Ohki M
Leukemia; 2001 Jan; 15(1):89-94. PubMed ID: 11243405
[TBL] [Abstract][Full Text] [Related]
37. MOZ-mediated repression of p16(INK) (4) (a) is critical for the self-renewal of neural and hematopoietic stem cells.
Perez-Campo FM; Costa G; Lie-A-Ling M; Stifani S; Kouskoff V; Lacaud G
Stem Cells; 2014 Jun; 32(6):1591-601. PubMed ID: 24307508
[TBL] [Abstract][Full Text] [Related]
38. MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells.
Sheikh BN; Yang Y; Schreuder J; Nilsson SK; Bilardi R; Carotta S; McRae HM; Metcalf D; Voss AK; Thomas T
Blood; 2016 Nov; 128(19):2307-2318. PubMed ID: 27663673
[TBL] [Abstract][Full Text] [Related]
39. A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.
Carapeti M; Aguiar RC; Goldman JM; Cross NC
Blood; 1998 May; 91(9):3127-33. PubMed ID: 9558366
[TBL] [Abstract][Full Text] [Related]
40. Ring1A and Ring1B inhibit expression of Glis2 to maintain murine
Shima H; Takamatsu-Ichihara E; Shino M; Yamagata K; Katsumoto T; Aikawa Y; Fujita S; Koseki H; Kitabayashi I
Blood; 2018 Apr; 131(16):1833-1845. PubMed ID: 29371181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
